About
Small Molecule Manufacturing
Areas of Focus
Categories
Contract ManufacturingPortugal
Clinical Trials (24)
View allTotal Trials
24
As Lead Sponsor
20
As Collaborator
4
Total Enrollment
2,546
By Phase
PHASE1: 18PHASE2: 3PHASE1/PHASE2: 1NA: 1PHASE2/PHASE3: 1
By Status
COMPLETED: 23UNKNOWN: 1
Clinical Trials Pipeline24 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05349396Lead Sponsor
Bioavailability of Eszopiclone 3.0 mg With Regards to Reference Product
PHASE1Completed
28 participants
Started: Apr 11, 2022 · Completed: Apr 19, 2022
NCT05332106Lead Sponsor
Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product
PHASE1Completed
10 participants
Started: Mar 12, 2022 · Completed: Mar 22, 2022
NCT05282940Lead Sponsor
Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product
PHASE1Completed
36 participants
Started: Feb 26, 2022 · Completed: Apr 8, 2022
NCT05250141Lead Sponsor
Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product
PHASE1Completed
44 participants
Started: Feb 14, 2022 · Completed: Feb 17, 2022
NCT05142553Collaborator
Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.
PHASE2Completed
887 participants
Started: Nov 16, 2021 · Completed: May 29, 2023
Locations (1)
Headquarters
Castanheira do Ribatejo e Cachoeiras, Portugal
Map
Loading map...